Cerus
California, United States
501-1000 Employees
Automotive
•Healthcare
•Tech
Drug Product Development & Manufacturing Manager
Concord, --
Description
Cerus Corporation (NASDAQ: CERS) is a biomedical company founded in 1996, dedicated to safeguarding the world's blood supply through innovative technologies. Their groundbreaking INTERCEPT Blood System sets a new standard in blood safety by inactivating a broad range of pathogens, making transfusions safer for patients worldwide. Cerus is at the forefront of advancing blood safety practices, ensuring the integrity of the global blood transfusion process.
Financials
Type
public
Annual Revenue
--
Market Cap
$289.8M+
Subscribe to Refer Me premium to get referred to this role at Cerus!